Responses
Research letter
Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial
Compose a Response to This Article
Other responses
No responses have been published for this article.